FDA, industry not waiting for Congress on drug shortages
Few expect Congress to produce a quick solution to the problem of shortages, which remain an immediate threat to patient care
American Medical News
WASHINGTON — The Obama administration is permitting importation of one critical drug while a new third-party group seeks to help generic drugmakers coordinate to avoid shortages.
Pending legislation in Congress and efforts by the private sector aimed at reducing national drug shortages largely aim to improve communication among manufacturers, distributors, federal regulators, hospitals and physicians to prevent supply problems from arising in the first place.
Copyright © 2013 LexisNexis, a division of Reed Elsevier Inc. All rights reserved.
Join the discussion
The comments below are member-generated and do not necessarily reflect the opinions of EMS1.com or its staff. If you cannot see comments, try disabling privacy and ad blocking plugins in your browser. All comments must comply with our Member Commenting Policy.